The Lion Consulting Group has been serving the biotechnology industry since 1983 with a broad range of services positioned at the intersection of technologies and markets.  Led by Ken Rubenstein, Ph.D., The Lion Consulting Group forms ad hoc virtual teams of experienced consultants with skills customized to the task at hand.                                                                                

The Group provides a broad range of consulting services with special focus on opportunities assessment, market analysis, strategic planning, technology evaluation, and litigation support.                                                        

Our mission is to provide busy clients with the information and clarifications needed to make cogent decisions in rapidly evolving markets, particularly those centered on genomics, post-genomics, and enabling technologies for drug discovery, and molecular diagnostics.